XML 47 R21.htm IDEA: XBRL DOCUMENT v3.25.2
Derivative Financial Instruments
9 Months Ended
Jun. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
The Company uses derivative financial instruments, primarily foreign currency forward exchange contracts, for the purposes of managing foreign currency exchange rate risk on expected future cash flows.
As of June 30, 2025, the Company had outstanding foreign currency forward exchange contracts for the sale of $197 million and the purchase of $124 million of foreign currencies at fixed rates that will be settled by September 2025. As of September 30, 2024, the Company had no foreign currency forward exchange contracts outstanding.
The Company recorded realized pre-tax gains of $7 million and unrealized pre-tax losses of $5 million related to its foreign currency forward exchange contracts in the condensed consolidated statement of operations as other expense for the nine months ended June 30, 2025. The Company recorded realized pre-tax losses of $1 million and unrealized pre-tax gains of $1 million related to its foreign currency forward exchange contracts in the condensed consolidated statement of operations as other expense for the nine months ended June 30, 2024.
The following is a summary of amounts recorded in the consolidated balance sheets pertaining to the Company’s derivative instruments at June 30, 2025 and September 30, 2024:
June 30,
2025
September 30,
2024
(in millions)
Other Current Assets:
Foreign currency forward exchange contracts (a)
— 
Other Current Liabilities:
Foreign currency forward exchange contracts (a)
(6)— 
______________________________________
(a)Includes $9 million and $14 million of foreign exchange derivative contracts in asset and liability positions, respectively, which net to $1 million of current assets and $6 million of current liabilities, respectively.